EMA: Guidance on the format of the risk management plan (RMP) in the EU – in integrated format

General consideration and guidance. This guidance should be read in conjunction with GVP module V. According to GVP module V, the aim of a risk management plan (RMP) is to document the risk management system considered necessary to identify, characterise and minimise the important risks of a medicinal product.